1075715-49-9Relevant academic research and scientific papers
Azaisoquinolinone derivatives as NK3 antagonists
-
Paragraph 0141, (2013/07/31)
The invention relates to compounds useful in therapy, in particular in the treatment of psychosis, to compositions comprising said compounds, and to methods of treating diseases comprising the administration of said compounds.
Pyridone derivatives as NK3 antagonists
-
Page/Page column 14, (2011/06/26)
The present invention relates to compounds useful in therapy, in particular in the treatment of psychosis, to compositions comprising said compounds, and to methods of treating diseases comprising the administration of said compounds.
PYRIDONE DERIVATIVES AS NK3 ANTAGONISTS
-
Page/Page column 33, (2011/07/07)
The present invention relates to compound of formula (I) useful in therapy, in particular in the treatment of psychosis, to compositions comprising said compounds, and to methods of treating diseases comprising the administration of said compounds.
AZAISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS
-
Page/Page column 11, (2011/10/04)
The invention relates to compounds useful in therapy, in particular in the treatment of psychosis, to compositions comprising said compounds, and to methods of treating diseases comprising the administration of said compounds.
AZAISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS
-
Page/Page column 27, (2011/10/05)
The invention relates to compounds useful in therapy, in particular in the treatment of psychosis, to compositions comprising said compounds, and to methods of treating diseases comprising the administration of said compounds.
ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS
-
Page/Page column 52-53, (2010/04/06)
The invention relates to isoquinolinone derivatives useful in therapy, in particular in the treatment of psychosis, to compositions comprising said compounds, and to methods of treating diseases comprising the administration of said compounds.
ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS
-
Page/Page column 26, (2010/04/23)
The invention relates to compounds useful in therapy, in particular in the treatment of psychosis, to compositions comprising said compounds, and to methods of treating diseases comprising the administration of said compounds.
ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS
-
Page/Page column 39, (2010/05/13)
Isoquinolone derivatives of the general formula (I) are NK3 antagonists.
ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS
-
Page/Page column 45, (2009/06/27)
Isoquinolone derivatives of the general formula are provided. The compounds are NK3 antagonists and useful for the treatment of e.g. psychosis and schizophrenia.
ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS
-
Page/Page column 35, (2010/01/30)
Isoquinolone derivatives of the general formula I are provided. The compounds are NK3 antagonists and useful for the treatment of e.g. psychosis and schizophrenia.
